Literature DB >> 25144921

Changes in RFamide-related peptide-1 (RFRP-1)-immunoreactivity during postnatal development and the estrous cycle.

Sara R Jørgensen1, Mille D Andersen, Agnete Overgaard, Jens D Mikkelsen.   

Abstract

GnRH is a key player in the hypothalamic control of gonadotropin secretion from the anterior pituitary gland. It has been shown that the mammalian counterpart of the avian gonadotropin inhibitory hormone named RFamide-related peptide (RFRP) is expressed in hypothalamic neurons that innervate and inhibit GnRH neurons. The RFRP precursor is processed into 2 mature peptides, RFRP-1 and RFRP-3. These are characterized by a conserved C-terminal motif RF-NH2 but display highly different N termini. Even though the 2 peptides are equally potent in vitro, little is known about their relative distribution and their distinct roles in vivo. In this study, we raised an antiserum selective for RFRP-1 and defined the distribution of RFRP-1-immunoreactive (ir) neurons in the rat brain. Next, we analyzed the level of RFRP-1-ir during postnatal development in males and females and investigated changes in RFRP-1-ir during the estrous cycle. RFRP-1-ir neurons were distributed along the third ventricle from the caudal part of the medial anterior hypothalamus throughout the medial tuberal hypothalamus and were localized in, but mostly in between, the dorsomedial hypothalamic, ventromedial hypothalamic, and arcuate nuclei. The number of RFRP-1-ir neurons and the density of cellular immunoreactivity were unchanged from juvenile to adulthood in male rats during the postnatal development. However, both parameters were significantly increased in female rats from peripuberty to adulthood, demonstrating prominent gender difference in the developmental control of RFRP-1 expression. The percentage of c-Fos-positive RFRP-1-ir neurons was significantly higher in diestrus as compared with proestrus and estrus. In conclusion, we found that adult females, as compared with males, have significantly more RFRP-1-ir per cell, and these cells are regulated during the estrous cycle.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144921     DOI: 10.1210/en.2014-1274

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Gonadotrophin-inhibitory hormone and its mammalian orthologue RFamide-related peptide-3: Discovery and functional implications for reproduction and stress.

Authors:  L J Kriegsfeld; K J Jennings; G E Bentley; K Tsutsui
Journal:  J Neuroendocrinol       Date:  2018-07       Impact factor: 3.627

Review 2.  GnIH Control of Feeding and Reproductive Behaviors.

Authors:  Kazuyoshi Tsutsui; Takayoshi Ubuka
Journal:  Front Endocrinol (Lausanne)       Date:  2016-12-27       Impact factor: 5.555

3.  Comparative and Evolutionary Aspects of Gonadotropin-Inhibitory Hormone and FMRFamide-Like Peptide Systems.

Authors:  Takayoshi Ubuka; Kazuyoshi Tsutsui
Journal:  Front Neurosci       Date:  2018-10-18       Impact factor: 4.677

Review 4.  The roles of RFamide-related peptides (RFRPs), mammalian gonadotropin-inhibitory hormone (GnIH) orthologues in female reproduction.

Authors:  Huimei Wang; Arezoo Khoradmehr; Mohammad Jalali; Mohammad Saied Salehi; Kazuyoshi Tsutsui; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2018-12       Impact factor: 2.699

Review 5.  Reproductive neuroendocrinology of mammalian gonadotropin-inhibitory hormone.

Authors:  Takayoshi Ubuka; Kazuyoshi Tsutsui
Journal:  Reprod Med Biol       Date:  2019-04-17

Review 6.  RFRP Neurons - The Doorway to Understanding Seasonal Reproduction in Mammals.

Authors:  Jo B Henningsen; François Gauer; Valérie Simonneaux
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-03       Impact factor: 5.555

Review 7.  The Role of GnIH in Biological Rhythms and Social Behaviors.

Authors:  Chuin Hau Teo; Brandon Phon; Ishwar Parhar
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.